Return to Medical Devices Alert Section
Selenium, Ltd. Receives STTR Grant from the National Institutes of Health to Develop Antimicrobial Dental Devices and Water Lines
November 26th, 2007
2007 NOV 26 -- Selenium, Ltd. announced the receipt of a Small Business Technology Transfer (STTR) grant from the National Institutes of Health in support of the development of antimicrobial dental devices and water lines. The company's SeLECT(TM) technology addresses the needs of many biomedical and industrial companies for a less expensive, more effective, and safer antimicrobial or antineoplastic coating technology. Dr. Julian Spallholz and Dr. Ted Reid are Co-Chief Scientists of Selenium and both are professors at Texas Tech University. Selenium, Ltd. is funded and managed by life sciences venture firm, Emergent Technologies, Inc. (ETI). "The grant from the National Institutes of Health is an additional validation of the importance of our chemistry in dental and medical applications," said Selenium, Ltd. Managing Director, Kris Looney. "We will use this funding to develop proofs of concept of antimicrobial coatings to reduce risk of contamination or infection in the dentist office." Keywords: Antimicrobials, Dental Device, Medical Device, Emergent Technologies Inc. This article was prepared by Anti-Infectives Week editors from staff and other reports. Copyright 2007, Anti-Infectives Week via NewsRx.com.
Return to Medical Devices Alert Section
|
